PortfoliosLab logo

ARCA biopharma, Inc. (ABIO)

Equity · Currency in USD · Last updated Mar 28, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in ARCA biopharma, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $0 for a total return of roughly -100.00%. All prices are adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%NovemberDecember2023FebruaryMarch
-100.00%
326.07%
ABIO (ARCA biopharma, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ABIO

ARCA biopharma, Inc.

Return

ARCA biopharma, Inc. had a return of -12.70% year-to-date (YTD) and -12.33% in the last 12 months. Over the past 10 years, ARCA biopharma, Inc. had an annualized return of -39.25%, while the S&P 500 had an annualized return of 9.76%, indicating that ARCA biopharma, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-1.00%0.19%
Year-To-Date-12.70%3.59%
6 months-2.86%7.70%
1 year-12.33%-12.45%
5 years (annualized)-26.06%8.78%
10 years (annualized)-39.25%9.76%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-7.17%-0.00%
2022-11.97%4.37%-2.79%13.40%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ARCA biopharma, Inc. Sharpe ratio is -0.40. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.50NovemberDecember2023FebruaryMarch
-0.40
-0.52
ABIO (ARCA biopharma, Inc.)
Benchmark (^GSPC)

Dividend History


ARCA biopharma, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-100.00%
-17.08%
ABIO (ARCA biopharma, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the ARCA biopharma, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ARCA biopharma, Inc. is 100.00%, recorded on Jan 28, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Nov 16, 20005333Jan 28, 2022
-87.35%Sep 29, 1997385Apr 9, 1999190Jan 7, 2000575
-14.06%Aug 12, 19976Aug 19, 199714Sep 9, 199720
-7.58%May 26, 20001May 26, 20001May 30, 20002
-4.74%Apr 17, 20001Apr 17, 20001Apr 18, 20002
-2.74%Sep 15, 19972Sep 16, 19972Sep 18, 19974
-0.66%Sep 22, 19971Sep 22, 19971Sep 23, 19972

Volatility Chart

Current ARCA biopharma, Inc. volatility is 29.04%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


10.00%20.00%30.00%40.00%50.00%60.00%70.00%NovemberDecember2023FebruaryMarch
29.04%
17.88%
ABIO (ARCA biopharma, Inc.)
Benchmark (^GSPC)